These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
129 related items for PubMed ID: 549566
21. HLA-related control of spontaneous and antibody-dependent cell-mediated cytotoxic activity in humans. Santoli D, Trinchieri G, Zmijewski CM, Koprowski H. J Immunol; 1976 Sep; 117(3):765-70. PubMed ID: 956652 [Abstract] [Full Text] [Related]
22. Cytophilic and cytotoxic antibodies in sera of rabbits after allogeneic skin grafts. Matej H, Wieczorek Z. Arch Immunol Ther Exp (Warsz); 1975 Sep; 23(3):329-33. PubMed ID: 766723 [Abstract] [Full Text] [Related]
23. Characteristics of a cytotoxic human lymphocyte-dependent antibody. Wunderlich J, Rosenberg E, Connolly J, Parks J. J Natl Cancer Inst; 1975 Mar; 54(3):537-47. PubMed ID: 1168262 [Abstract] [Full Text] [Related]
24. The LDA assay, a new test for the detection of auto, allo and specific anti-leukemic lymphocytotoxic antibodies. Jeannet M, Vassalli P, Magnin C, Cruchaud A. Boll Ist Sieroter Milan; 1974 Mar; 53(1):suppl:187. PubMed ID: 4605371 [No Abstract] [Full Text] [Related]
26. [Evaluation of a new detection method for antilymphocyte alloantibodies and specific antileukemic antibodies]. Jeannet M, Vassalli P, Magnin C, Cruchaud A. Schweiz Med Wochenschr; 1974 Sep 28; 104(39):1388-9. PubMed ID: 4608510 [No Abstract] [Full Text] [Related]
29. Detection of anti-HLA-F antibodies in sera from cancer patients. Noguchi K, Isogai M, Kuwada E, Noguchi A, Goto S, Egawa K. Anticancer Res; 2004 Sep 28; 24(5C):3387-92. PubMed ID: 15515436 [Abstract] [Full Text] [Related]
30. Mixed organ culture as a tool for considering cellular tumor-host relationships in tumor patients. Nissen E, Tanneberger S. Arch Geschwulstforsch; 1976 Sep 28; 46(4):281-93. PubMed ID: 971045 [Abstract] [Full Text] [Related]
32. Generation of non-complement-fixing, blocking factors by lysosomal extract treatment of cytotoxic anti-tumor antibodies. Dauphinee MJ, Talal N, Witz IP. J Immunol; 1974 Sep 28; 113(3):948-53. PubMed ID: 4413555 [No Abstract] [Full Text] [Related]
33. Production in vitro of antibodies directed against alloantigen-specific recognition sites on T cells and on lymphocytotoxic HLA antibodies. Singal DP, Blajchman MA, Joseph S, Roberge B, Smith EK, Ludwin D. Clin Exp Immunol; 1988 May 28; 72(2):222-7. PubMed ID: 2970351 [Abstract] [Full Text] [Related]
35. [Lymphocytes HLA antigens expressivity after neuraminidase treatment (author's transl)]. de Mouzon A, Ohayon E, Oksman-Domejean F, Ducos J. Ann Immunol (Paris); 1976 May 28; 127(5):687-701. PubMed ID: 984732 [Abstract] [Full Text] [Related]
36. Cytotoxic antibodies to human leukaemia cells in normal human sera. Dore JF, Guibout C, Bertoglio J, Liabeuf A. Biomedicine; 1976 Dec 30; 25(10):382-4. PubMed ID: 1071010 [Abstract] [Full Text] [Related]
38. Workshop in human tumor immunology. Oettgen HF, Bean MA, Klein G. Cancer Res; 1972 Dec 30; 32(12):2845-53. PubMed ID: 4345410 [No Abstract] [Full Text] [Related]
39. In situ immune complexes, lymphocyte subpopulations, and HLA-DR-positive epithelial cells in Hashimoto thyroiditis. Aichinger G, Fill H, Wick G. Lab Invest; 1985 Feb 30; 52(2):132-40. PubMed ID: 3881622 [Abstract] [Full Text] [Related]
40. Immunological reactions involving leukocytes: I. Detection of antibodies to human granulocytes by measurement of the metabolic events associated with phagocytosis. Laleli YR, Bilezikian SB, Tsan MF, Hodkinson BA, McIntyre PA. Johns Hopkins Med J; 1976 Feb 30; 138(2):43-7. PubMed ID: 1249880 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]